title: Treatment of chronic prostatitis in Chinese men.
abstract: The aim of this study is to assess the status of treatment of chronic prostatitis (CP) in Chinese men. A population-based cross-sectional survey was performed, in which 15 000 men aged between 15 and 60 years were randomly selected to receive a questionnaire designed to assess National Institutes of Health Chronic Prostatitis Symptoms Index (NIH-CPSI) status, therapeutic efficacy and 28 other items. A total of 12 743 men (84.95%) completed the questionnaire, of whom 1 071 (8.4%) were identified as having prostatitis-like symptoms and 517 (4.5%) were diagnosed with CP according to NIH-CPSI criteria and prostatitis-like symptomatology. Of the CP patients, 372 (65%) underwent long-term routine treatment 12 times per year. Additionally, 217 (72.8%) patients received antibiotic therapy and 215 (79.3%) men showed therapeutic effects. The treatment cost USD 1 151 (8 059 yuan) per person per year on average. Most CP patients received routine treatment, in most cases with antibiotics. Treatment was costly and most CP patients were not satisfied with its effectiveness. Antibacterial treatment might have been effective primarily in patients with bacterial disease.
authors.affiliation: Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China. liang_chaozhao@163.com
authors.forename: Chao-Zhao
authors.initials: CZ
authors.lastname: Liang
authors.forename: Hong-Jun
authors.initials: HJ
authors.lastname: Li
authors.forename: Zhi-Ping
authors.initials: ZP
authors.lastname: Wang
authors.forename: Jun-Ping
authors.initials: JP
authors.lastname: Xing
authors.forename: Wei-Lie
authors.initials: WL
authors.lastname: Hu
authors.forename: Tao-Fu
authors.initials: TF
authors.lastname: Zhang
authors.forename: Wei-Wei
authors.initials: WW
authors.lastname: Ge
authors.forename: Zong-Yao
authors.initials: ZY
authors.lastname: Hao
authors.forename: Xian-Sheng
authors.initials: XS
authors.lastname: Zhang
authors.forename: Jun
authors.initials: J
authors.lastname: Zhou
authors.forename: Yu
authors.initials: Y
authors.lastname: Li
authors.forename: Zheng-Xing
authors.initials: ZX
authors.lastname: Zhou
authors.forename: Zhi-Guo
authors.initials: ZG
authors.lastname: Tang
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D002681:China / Q000453:epidemiology; D002908:Chronic Disease; D003430:Cross-Sectional Studies; D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011472:Prostatitis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D004365:Drugs, Chinese Herbal